Quantum Dots Advance Cancer Therapy with Enhanced Imaging and Drug Delivery, Overcoming Toxicity Barriers for Clinical Translation

September 6, 2026

IJPS Journal Global

Overview

This review emphasizes quantum dots (QDs) are extensively researched for bioimaging and drug delivery in cancer therapy due to their unique optical properties, particularly intense fluorescence. QDs can address challenges in biomedical imaging by tuning their size, shape, composition, and surface properties. Cadmium-containing QD toxicity, a previous hurdle, is now being overcome through surface modifications and advances in cadmium-free QDs, paving the way for clinical applications.

In Depth

Key Findings

This review article emphasizes that quantum dots (QDs), nanoscale semiconductor crystals, are subjects of extensive research in bioimaging and drug delivery for cancer therapy, primarily due to their unique optical properties, especially intense fluorescence. QDs hold significant potential to overcome existing challenges in biomedical imaging and therapeutic strategies by precisely tuning their size, shape, composition, and surface characteristics. The toxicity of cadmium-containing QDs, a former major barrier, is now being mitigated through innovative surface modification techniques and the development of cadmium-free QDs.

Technical / Clinical Details

Quantum dots are extremely small semiconductor crystals, ranging from a few to tens of nanometers. Due to the quantum confinement effect, their light absorption and emission properties are size-dependent. This characteristic allows QDs to emit multiple distinct colors of light from a single excitation wavelength, which is highly advantageous for multiplex imaging. The application of QDs in cancer therapy is progressing mainly in two aspects:

Bioimaging: The bright fluorescence and high photostability of QDs are utilized for detecting cancer cells at a cellular level, delineating tumor margins, and early detection of metastases. Furthermore, by functionalizing their surface to bind to specific biomarkers, QDs enable targeted imaging of cancer cells.
Drug Delivery Systems: QDs, with their large surface area and internal volume, can load anticancer drugs or gene therapies. By modifying their surface with biocompatible polymers (e.g., PEG) and attaching cancer-specific ligands (e.g., antibodies, peptides), drugs can be selectively delivered to tumor sites, minimizing impact on healthy tissues.

While the toxicity of cadmium-containing QDs remains a concern, surface modification with biocompatible materials like PEG (polyethylene glycol) can reduce toxicity and enhance in vivo stability. Additionally, advances in cadmium-free QDs, such as indium phosphide (InP) and silicon (Si), are providing safer alternatives.

Background & Context

Cancer continues to be a leading cause of death globally, and improving its diagnosis and treatment is an urgent public health imperative. Conventional cancer imaging technologies have limitations in sensitivity and specificity, and many drug delivery systems often face challenges such as systemic side effects and insufficient drug accumulation at tumor sites. The application of nanotechnology, particularly QDs, is highly anticipated as an innovative solution to these problems. Specifically, with the advancement of Precision Medicine, the concept of Theranostics, combining diagnosis and therapy, is gaining traction, and QDs could become an indispensable platform technology for its realization.

Strategic Significance & Outlook

For the clinical application of quantum dots in cancer therapy, further research into toxicity, biodistribution, long-term in vivo kinetics, and ex vivo clearance is essential. Optimization of cadmium-free QD performance and advances in surface modification techniques will be key directions to accelerate practical implementation. In the future, QD-based imaging and drug delivery systems hold the potential to dramatically improve cancer patient prognosis by enabling early diagnosis, personalized treatment strategies, and real-time monitoring of therapeutic effects. This will establish the position of QDs in nanomedicine and provide more effective and safer cancer treatment options globally.

Source: https://www.ijpsjournal.com/article/quantum-dots-for-imaging-and-drug-delivery-in-cancer-therapy

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.